CAD0.24
4.35% yesterday
Toronto, Nov 15, 09:09 pm CET
ISIN
CA81732W1041
Symbol
SVA
Sector
Industry

Sernova Stock price

CAD0.24
-0.03 11.11% 1M
-0.11 31.43% 6M
-0.46 65.71% YTD
-0.46 65.71% 1Y
-1.24 83.78% 3Y
+0.04 20.00% 5Y
+0.07 41.18% 10Y
Toronto, Closing price Fri, Nov 15 2024
+0.01 4.35%
ISIN
CA81732W1041
Symbol
SVA
Sector
Industry

Key metrics

Market capitalization CAD74.82m
Enterprise Value CAD70.39m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio negative
Revenue (TTM) Revenue CAD0.00
EBIT (operating result TTM) EBIT CAD-39.08m
Free Cash Flow (TTM) Free Cash Flow CAD-26.32m
Cash position CAD5.02m
EPS (TTM) EPS CAD-0.13
P/E forward negative
Show more

Is Sernova a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Sernova Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Sernova forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Sernova forecast:

Buy
100%

Financial data from Sernova

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '24
+/-
%
- -
-
100%
- Direct Costs 0.49 0.49
11% 11%
-
-0.49 -0.49
11% 11%
-
- Selling and Administrative Expenses 8.62 8.62
11% 11%
-
- Research and Development Expense 29 29
1% 1%
-
-39 -39
3% 3%
-
- Depreciation and Amortization 0.49 0.49
11% 11%
-
EBIT (Operating Income) EBIT -39 -39
3% 3%
-
Net Profit -39 -39
10% 10%
-

In millions CAD.

Don't miss a Thing! We will send you all news about Sernova directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded on August 19, 1998 and is headquartered in London, Canada.

Head office Canada
CEO Jonathan Rigby
Employees 26
Founded 1998
Website www.sernova.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today